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PURPOSE 
The purpose of this investigation will be to study the 
pharmacology of the polyamine spermidine in further detail. 
The general pharmacology, including acute toxicity, in vitro 
bioassay and in vivo physiologic responses will be described. 
The variability of the toxicity of spermidine during a programmed 
light-dark cycle will be studied. A possible interaction between 
spermidine and histamine will be studied in relation to the daily 
fluctuation of their levels in the central nervous system as well 
as their effect on pentobarbital-induced sleeping time. 
ix 
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INTRODUCTION 
HISTORY,DEFINITION AND CHEMISTRY 
The polyamines are a diverse group of nitrogenous bases widely 
distributed throughout nature. They include aliphatic , heterocyclic 
and aromatic derivatives but most recent interest has centered on a 
series of aliphatic di- and polyamines. The structures of the major 
members of this group are seen in Table I . 
Antoni Van Leeuwenhoek is credited with the recognition of 
crystais of spermine in samples of human semen ( Leeuwenhoek , 
A. Van,l678 ; Smith,T.A. , 1972 ). It was not until well over two 
hundred years later however that the correct structure of spermine 
was established and its synthesis accomplished ( Dudley,H.W. et al., 
1926 ). 
/ 1 
NH2(CH2)3NH2 
NH2(CH2)4NH2 
THE ~1AJOR POLYM1INES 
.......................... 
.......................... 
.......................... 
1,3- diaminopropane 
1,4- diaminobutane 
(putrescine) 
1,5- diaminopentane 
(cadaverine) 
NH2(CHz)3NH(CH2)4NH2 ••..........••.... spermidine 
TABLE I 
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OCCURRENCE IN BIOLOGIAL MATERIAL 
PLANTS 
There has been relatively little interest in the presence and 
possible role of polyamines in plant material (Smith, T.A., 1972). 
Putrescine is the major member of the series found in most plant 
species (Smith,T.A., 1970). Spermidine and spermine are also present 
in most higher plants in quantities ranging from 0.01 - 0.25 
3 
micromoles per gram (Smith, T.A., 1970). These compounds are predominant-
ly found in the leaves of these plants and in the embryo of the seed, 
particularly during earlier stages of germination. 
BACTERIA AND VIRUSES 
Polyamines are found in relatively high concentration in T-even 
bacteriophages of E. coli (Ames et al., 1958). They are present in 
concentrations which can neutralize up to forty percent of the DNA 
phosphorus of the virus. Unlike many strains of bacteria, the 
bacteriophage does not take up polyamines from the medium and thus 
their presence in these organisms represents the best evidence 
for the in vivo associ at ion of the polyamines and nucleic acids. 
4 
Spermidine and trace quantities of spermine have been identified 
as constituents of Turnip Yellow Mosaic virus (TYMV). The total 
< :. io. 
amount found would be sufficient to neutralize approximately twenty 
percent of the viral RNA (Beer, ·s.v. and Kosuge, T., 1970). 
Polyamines are found in a variety of bacteria, yeasts and fungi 
(Tabor, H. and Tabor~ C.W., 1972). Their concentra~ion in bacteria 
is in part dependent on the characteristics of the medium used and 
the conditions of growth present. Higher concentrations are found 
when organisms are grown in a medium enriched with polyamines. The 
mechanisms of uptake of polyamines by E. coli have been studi~d by 
Tabor and Tabor (1966). They described (a) a non-energy dependent 
adsorption of amines onto the cell surface and (b) an energy-dependent 
uptake, stimuiated by glucose~ into the interior of the cell. Higher 
concent.rations of polyamines are also found during periods of growth 
of bacterial cultures. Gram-negative bacteria contain large amounts 
of polyamines· while gram-positives contain relatively little or none 
at all (Herbst et al., 1958). 
Significant quantities of polyamines are found in the fungus 
Neurospora crassa. A magnesium deficient medium can stimulate polyamine 
synthesis in this orgnaism (Viotti, A., et al., 1971). 
/ 
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ANIMALS 
The highest concentrations of spermidine and spermine in animal 
tissues.are found in pancreas, prostate and human semen (Rosenthal, S.M. 
and Tabor, C.W., 1956; Tabor, H. and Tabor, C.W., 1964). The high 
concentration of spermine in human semen forms the basis for some 
medicolegal studies. Table II summarizes the reported levels of 
spermidine and spermine in selected animal tissues. 
Pfeiffer et al. (1970) and Iliev et al. (1968) have studied 
polyamine levels in whole blood of humans. Levels of spermidine were 
detectable in the range of 0.9 to l.Omg./ml. and the concentration 
·, ·' 
of spermine was 1.38 to 1.48 mg./ml. They found no correlation with 
the age or sex of the subjects. 
The molar ratio of spermidine to spermine varies with the 
tissue and its stage of development (see below) but in general the 
ratio is between 1.0 and 2.0 except in the case of testes, kidney, 
skeletal muscle and human semen and prostate, where the ratio is 
less than one in most species. Janne et al. (1964) have shown in 
the rat that levels of spermidine decrease significantly after birth 
in all 
6 
THE CONCENTRATION OF POLYAMINES IN SELECTED 
ANIMAL TISSUES 
ORGAN ANIMAL SOURCE SPERMIDINE SPERMINE ( ug/gm ) {ug/gm} 
Semen Human trace 3300 
Prostate Human 495 
Rat 1122 1155 
Liver Human 495 
Rat 230 235 
Mouse 235 155 
Spieen Human 45 
Rat 230 134 
Bone Marrow Human 148 
Pancreas Rat 1250 194 
Mouse 410 202 
Guinea pig 312 280 ' 
Testis Rat 55 105 
TABLE II 
/ 
tissues examined while spermine shows relatively little change except 
in the case of brain and skeletal muscle. Thus, the molar ratio of 
the two decreases over the first few months of life. 
By radioautography, Dion and Herbst (1967) have shown a 
localization of spermidine within the nucleus of the salivary gland 
of Drosophila melanoqaster. Application of this technique to the 
intracellular localization of polyamines in other systems has not been 
successful. 
The presence of spermidine and spermine in neural tissue was 
unappreciated until Kremzer {1966) and Michaelson (1967) identified 
them as contaminants in the existing method for the detection of 
histamine. That method, described by Shore, Burkhalter and Cohn in 
i959, involved the n-butanol extraction of alkalinized perchloric 
acid tissue extracts which were then condensed with o-pthaldialdehyde 
(OPT) to form a fluorescent product. (Histamine and spermidine have 
very similar fluorescence spectra when complexed with OPT. Both 
are maximally activated at 350 mu.) Histamine is read at 450 mu and 
spermidine at 400 mu. Using this method Michaelson and Dowe (1963) 
7 
had reported histamine levels of 2.2 nanomoles per gram of guinea pig 
brain. Carlini and Green (1963) reported similar levels of 2.2 nanomoles 
per- gram using the same method but found only 0.48 nanomoles per gram 
/ 
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when a biological assay {guinea pi~ ileum) was used. In a study 
of the diurnal variability of histamine levels in rat caudate nucleus, 
Friedman and Walker (1968) reported histamine levels ranging from 
10.5 to 20.1 nanomoles per gram. Eliminating spermidine and spermine 
using the method of Anton and Sayre (1968) the true levels of 
histamine were subsequently found to vary between 0.63 and 1.08 
nanomoles per gram (Friedman, A.H. and Walker, C.A., 1969). Thus~ 
spermidine and spermine were present in the rat caudate nucleus in a 
concentration twenty times that of histamine. The method of Kremzer 
has subsequently been modified to separate histamine, spermidine 
and spermine (Medina, M. and Short, P.A., 1966; Iliev, V. et al., 
1968; Hakanson, R., and Roonberg, A., 1973). Michaelson has found the 
phosphorylated cellulose resin used in the· latter methods unreliable 
and has subsequently described the use of another phosphonic acid cation 
exchange resin, Bio-Rex-63 (Bio-Rad Laboratories, Richmond, California) 
which is more stable and consistent (Michaelson, I.A. and Coffman, P.A., 
( 1969). It is. the method of Mi chae 1 son and Coffman that has been 
modified for use in this study. A highly sensitive and specific 
enzymatic isotopic method for histamine has subsequer:~tly been devised 
(Snyder, S.H., et al., 1966; Taylor, K.M. and Snyder, S.H., 1971; 
Taylor, K.M. and Snyder, S.H., 1972). Reference will be made to results 
obtained with this method. More recent methods for the detection of 
polyamines have been described utilizing alternate cation exchange 
resins (Marton et al.~l973; Tabor,H. and Tabor,C.W.,l973) or 
gas chromatography (Denton,M.D. et al.,l973). Recently a method 
9 
has been developed for the detection of putrescine (Harik,S.I. et al., 
1973). 
Significant levels of spermidine and spermine are present in 
both the central and peripheral nervous systems. Reported concen-
trations have been variable, in part a function of the methodology 
employed but perhaps also,as will be shown later in this study, a 
function of the point in the light-dark cycle at which the tissues 
were taken. Tables III and IV summarize levels reported in whole brain 
homogenates of several species. 
Despite their structural similarity and metabolic interrelation-
ships, the regional distribution of spermidine and spermine are not 
similar. Shaw and Pateman (1973) studied the levels of these amines 
in selected brain areas of multiple species. In a thorough analysis 
of sheep brain, highest levels of spermidine were detected in regions 
rich in myelinated fiber tracts such as subcortical white matter 
(115 ug/gm), cerebellar white matter (102ug/gm), pons (112ug/gm) 
and optic chiasm (118 ug/gm}. Significantly lower levels were found 
in neuronal masses such as cortical grey (25ug/gm), caudate nucleus 
(24 ug/gm) and hypothalamus (37 ug/gm). Although absolute values 
/ 
ANIMAL 
Guinea pig 
Rabbit 
House 
Rat 
Fish 
REPORTED LEVELS ·oF SPERMIDINE IN WHOLE BRAIN 
OF VARIOUS SPECIES 
WHOLE BRAIN 
SPERMIDINE 
(ug/gm) 
35.2 
45-48 
62-71 
65 
40 
45 
98 
44 
70 
62 
REFERENCE 
Kremzer (1966) 
Kremzer (1966) 
Shimizu et a1. (1964) 
Seiler (1973) 
Shimizu et a1. (1965) 
Giorgi et al. (1972) 
Rosenthal and Tabor (1956) 
Kremzer (1970) 
Pearce and Schanberg (1969) 
Seiler and Lamberty (1973) 
TABLE Ill 
10 
i. 
ANIMAL 
Rabbit 
Mouse 
Rat 
Fish 
/ 
REPORTED LEVELS OF SPERt~INE IN WHOLE BRAIN 
OF VARIOUS SPECIES 
WHOLE BRAIN 
SPERMINE 
(ug/gm) 
REFERENCE 
Shimizu et a1. (1964) 
Giorgi et a1. (1972) 
Tabor and Tabor (1964) 
29 
41 
41 
19 Sei 1 er and· Lamberty ( 1973) 
TABLE IV 
·. 
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varied somewhat, essentially similar distributions were found in rat, 
rabbit, dog and human specimens. Cervical cord was studied in the 
rat and rabbit and contained higher concentrations of spermidine than 
any other area assayed. Studies of rat brain by Shimizu (1964) 
showed a similar distribution and included analysis of peripheral 
(sciatic) nerve which contained relatively low levels compared to areas 
rich in central rather than peripheral myelin. Kremzer (1970) and 
Kremzer et al.(l970) also analysed human brain with results similar 
to those of Shaw and Pateman. In addition , no significant difference 
was found in the spermidine concentration of different cortical areas. 
(Cortical white matter contains considerably more spermidine, 92-
122ug/gm , than adjacent cortical ribbon, 20-38ug/gm.(Shaw and 
Pateman,l973) ). The concentration of spermidine in rat caudate 
nucleus was found to be 60ug/gm by Shimizu et al.(l964) while the 
concentration of authentic histamine in this structure is 0.05-0.15 
ug/gm (Friedman and Walker ,1969), explaining the spuriously high 
levels of histamine reported when spermidine was not separated prior 
to condensation with OPT. 
Shaw and Pateman (1973) found less remarkable and less consistent 
regional variability of spermine levels. In sheep brain , highest 
levels were found in the pituitary,trigeminal nerve base, optic 
chiasm, lateral geniculate bodies and the cerebral peduncles. Exam-
ination of two human brains shewed inconsistent levels but there was a 
tendency toward high levels in more caudal brain areas, i.e. areas 
of the brainstem. In rabbit brain Shimizu et al. (1964) found 
highest levels of spermine in cortex and caudate nucleus (36ug/gm) 
with a progressive decline in more caudal regions such as lumbar 
spinal cord (9ug/gm) and sciatic nerve (5ug/gm). Kremzer et al. 
(1970) did not find any significant difference in the spermine 
concentration in several areas of sheep brain. 
Neither Shaw and Pateman (1973) nor Kremzer et al. (1970) 
could find detectable levels of spermidine or spermine in human 
cerebrospinal fluid. \ 
The absence of a reliable method for the determination of 
putrescine has limited studies of this compound. Employing an 
enzymatic-isotopic assay found to be both sensitive and specific, 
Harik et al. (1973) have detected significant levels of putrescine 
in mouse brain (0.17ug/gm) and rat brain (0. 17u§/gm). 
13 
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METABOLISM 
SYNTHESIS 
The biosynthesis of putrescine , spermidine and spermine has 
been well characterized in microorganisms, particularly E. coli 
(Bachrach, U., 1970; Tabor, H. and Tabor, C.W., 1972). Studies 
of animal tissue have included chick embryo (Raina, A., 1963), rat 
liver, especially during regeneration (Janne, J., 1967; Slimes, M., 
1967; Russell, D.H. and Snyder, S.H., 1969; Snyder, S.H. and 
14 
Russell, D.H., 1970; Russell, D.H. and McVicker, T.A., 1971) and rat 
prostate (Pegg, A.E., 1970; Pegg, A.E. and Williams-Ashman, H.G., 1970). 
A review of preliminary studies of higher plants has recently been 
presented by Smith (1970). 
In all organisms studied the formation of spermidine involves 
the addition of a propylamine group to 1,4-diaminobutane as seen in 
Figure 1. S-adenosylmethionine (SAMe) is perhaps most important in 
biological systems as an active methyldonor (Baldessarini, R.J., and 
Kopin, I.J., 1966). · Enzymes for its formation from ATP and methionine 
FIGURE 1. BIOSYNTHESIS OF SPERMIDINE 
cH3 coo-
' I SCH2CH2CH NH2 
1- methionine 
yHs 9oo-
adenine- ribose -SCH2CH2CHNH2 
S-adenosylmethi~nine (SAMe) 
CH3 
1.4-diamincbutane -----adenine- ribose-SJCH2CH2CH2NH2j 
NJi:2CH2CH~H:2NHCH.2C~~H:2N~ + methylthioadenosine 
spermidine 
15 
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are present in most organisms. SAMe is decarboxyl a ted enzymatically 
as seen in the figure. In mammalian systems this enzyme is markedly 
dependent on the presence of 1,4-diaminobutane (Pegg, A.E., and 
Williams-Ashman, H.G., 1968). Mg++ is required for the enzyme found 
in E.coli. A pyridoxal phosphate inhibitor, NSD-1055 inhibits the 
mammalian enzyme but not the E. coli enzyme. Recently, methylgloxal 
Bis (guanylhydrazine) has been shown to be a specific competitive 
inhibitor of SAMe decarboxylase (Williams-Ashman, H.G. and 
Schenone, A., 1972; Pegg, A.E., 1973). 
Propylamine transferase catalyses the last step in the formation 
of spermidine. The purified enzyme has no known cofactors. Negative 
feedback is exerted on its activity by the products of the reaction. 
Although in some systems spermidine may act as a substrate of the same 
enzyme (resulting in the formation of spermine), this is not the 
case in mammalian systems (Janne, J. et al., 1971). A second enzyme 
for the formation of spermine from SAMe and spermidine has been purified 
from both rat brain and regenerating rat liver (Hannonen, P. et al. 1971; 
Hannonen, et al., (1972). 
In the central nervous system, SAMe-Decarboxylase activity is 
highest in the cerebral cortex and cerebellum (Snyder et al., 1973). 
After intraventricular injection of labelled putrescine, these investigators 
:1 
.I 
I 
.I 
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found that virtually all of the putrescine had been converted to 
spermidine and spermine by 48 hours. Like tracer doses of other amines 
such as tyrosine and histidine, 60 to 70% of the dose was convert-
ed within the first twenty minutes. Overall, spermine accounted for 
only 10 to 25% of the activity detected. The tracer was initially 
distributed to midbrain, hypothalamus and cerebellum but levels declined 
sharply in these regions. Spermidine activity was detected as early 
as twenty minutes and reached peak levels in medulla-pons, internal 
capsule and corpus striatum by 48 hours. Activity in spermine could not 
be detected until 48 hours and peak levels did not occur until the 
fifteenth to nineteenth days, particularly in cerebral cortex and 
cerebellum. 
Kremzer et al. (1970) studied the regional distribution of 
propylamine transferase activity in several regions of sheep brain. 
Like SAMe decarboxylase activity and in contrast to the distribution of 
ornithine decarboxylase, highest levels were found in the cerebral 
cortex. 
In animal tissue, ornithine is the only source of putrescine 
for polyamine synthesis. The conversion is catalysed by ornithine 
decarboxylase, a specific enzyme found in most tissues. It has been 
purified from rat prostate (Janne, J. and Williams-Ashman, H.G., 1970) 
and regenerating rat liver (Friedman, S.J., et al, 1972) and found to 
18 
require pyridoxal phosphate as a cofactor. Its activity is stimulated 
by its substrate but also by several hormones including testosterone 
(rat prostate), hydrocortisone, growth hormone, ins~lfri, glucagon and 
thyroxin (rat liver) and luteinizing hormone (rat ovary)(Russell, et al., 
1970; Pegg, A.E., et al, 1970; Panko, W.B. and Kenney, F.T., 1971; 
Kobayaski, Y. et al, 1971). Harik et al. (1974) have shown 
alpha-hydrazino-ornithine to be a specific competitive inhibitor of the 
enzyme. Hayaski et al. (1972) have shown some diurnal variability in 
the activity or ornithine decarboxylase which they related to protein 
intake, but lighting conditions were not controlled in their study. 
Hernandez et al. (1973) have·shown variability or ornithine 
decarboxylase during the estrous cycle of rats, peak levels occurring 
during the proestrous phase. 
Both plants and bacteria can form 1,4-diaminobutane by an 
alternate pathway from arginine. Agmatine is formed by decarboxylation 
of arginine, catalysed by a specific enzyme not found in animals. 
Putrescine may be formed from agmatine with the production of urea. At 
leust in the case of E.coli, ornithine decarboxylase accounts for the 
synthesis of 75~98% of the putrescine (Morris et al., 1970). Plants, 
on the other hand, depend on arginine decarboxylase. 
Figure 2 summarizes the pathways of putrescine synthesis. 
/ 
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FIGURE 2. BIOSYNTHESIS OF 1,4·DIAMINOBUTANE 
Urea cycle 
/ 
citrulline arginine 
/ l -urea / 
ornithine 
agmatine 
1,4-diaminobutane 
20 
CATABOLISM 
Diamine oxidase is a copper-containing enzyme purified from hog 
kidney. It catalyses the oxidation of short chain diamines, as well as 
histamine, to the corresponding aldehyde. Gamma-aminobutyraldehyde, 
the product of putrescine oxidation, cyclizes to deltal-pyrroline or 
it may be further oxidized to gamma-aminobutyric acid (GABA) (Razin, S. 
et al., 1959). The functional significance of this pathway for the 
formation of the putative neurotransmitter GABA is unknown. 
Several bacterial species are capable of converting spermine to 
spermidine and beta-alanine. Spermidine may then be further cleaved 
to form another molecule of beta-alanine and GABA (Razin, S. et al., 
1959). 
Kakimoto et al. (1969) reported the presence of putreanine 
(N-(4-aminobutyl)-3-aminopropionic acid) in the brain of rabbits and 
rats. They felt this compound was unique to the nervous system since 
it was not detected elsewhere. Nakajima (1973) has subsequently de-
tected trace levels in rat liver and has demonstrated that it is a 
product of spermidine catabolism. The significance of its relative 
localization to central nervous tissue is unclear. 
!· ·.• 
PUTATIVE FUNCTIONS OF THE POLYAMINES 
INTERACTIONS WITH NUCLEIC ACIDS 
Low concentrations of polyamines ha.ve a remarkable stabilizing 
effect. on DNA. The melting temperature of DNA is marked'Iy increased 
in the presence of concentrations of spermine and spermidine as low as 
10-5M (Tabor, H., 1962; Stevens, L., 1970). The two more likely ways 
21 
this is accomplished are that either the amines neutralize the phosphate 
groups of.the DNA (reducing the mutual repulsion between ·the strands) 
or that they form bridges between the strands. X-ray diffraction and 
electron microscopic studies have favored the latter possibility 
(Chevaill:ier, P., 1969; Sutvalsky,M. et al., 1969). The polyamines do 
not alter the conformation of the DNA helix but, when interacting with 
RNA, this polynucleotide becomes folded and more compact. 
·Polyamines promote the associatinn of ribosomal subunits to form 
70S or 80S particles. Furthermore,. they promote the attachment of 
transfer -RNA and messenger -RNA to ribosomes. Finally, these compounds 
have been found in vitro to stimulate the activity of DNA-primed RN.l\ 
polymerase and possibly also DNA-primed DNA polymerase. Datta et a_l. (1969) 
/ 
and Giorgi {1970) have confirmed some of these observations in 
preparations of rat cerebral cortex. 
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In vivo studies of the association of nucleic acids and polyamines 
---
have not been accomplished. Because of their polycationic nature, the 
polyamines redistribute because of their tendency to associate with 
subcellular fractionation (Michaelson, I.A. and Smithson, H.R., 1971). 
GROWTH AND DEVELOPMENT 
In studies of chick embryo, Raina (1963) demonstrated a marked 
acceleration of de novo spermine and spermidine synthesis reaching peak 
values on the sixteenth day of incubation followed by a sharp decrease. 
A second increase in the concentration of these polyamines occurred 
between the tenth to fourteenth day after hatching, again followed by 
a sharp decline to adult levels. Similar results were obtained by 
Calderera et al. (1965) who demonstrated a close association with 
nucleic acid levels. Manen and Russell (1973) have shown a remarkable 
cyclic increase in ornithine decarboxylase and propylamine transferase 
activity in the early stages of sea-urchin embryogenesis. Enzyme 
activities increased soon after fertilization, reaching peak levels 
within thirty minutes. Enzyme activities and polyamine levels decreased 
just prior to each subsequent cleavage. Herbst and Dian (1970) have 
shown similar correlations in Drosophila. 
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Specifically in brain, Calderera et al (1969) have found peak 
polyamine levels twelve to fourteen days after fertilization. Levels 
then gradually decline but~ as in whole embryo and in other isolated 
organs, a second peak occurs ten to fourteen days after birth, declining 
thereafter to adult levels. Parallel changes are seen in nucleic acid 
levels. Pearce and Schanberg (1969) have made the interesting 
observation that histamine levels undergo similar changes but precede 
those of spermidine by 24 to 48 hours. 
An association between polyamines and accelerated tissue growth 
is apparent in several different models. In regenerating rat liver, 
ornithine decarboxylase activity triples one hour after partial hepatec-
tomy (Russell, D.H. and Snyder, S.H., 1969~). By four hours levels are 
ten times basai ieveis. Paraiiei changes occur in RNA leve-ls while 
increases in DNA do not occur until 16 or 18 hours later. Adminis-
tration of actinomycin D or cycloheximide prior to or up to thirty 
minutes after the operation prevents the increase in enzyme activity. 
Using these dfugs, the half~life of newly synthesized ornithine 
decarboxylase was found to be 11 minutes , the shortest known for 
mammalian enzymes (Russell, D.H. and Snyder, S.H., 1969b; Snyder, S.H. 
and Russell, D.H., 1970). Hypophysectomy also prevents much of the 
incr.ease in ornithine decarboxylase and treatment with growth hormone 
reverses this effect (Russell, D.H. and Snyder, S.H., l969c). 
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CENTRAL NERVOUS SYSTEM 
In the nervous system, Kremzer (1970) has found increased 
conversion of putrescine to spermidine in peripheral nerve adjacent 
to a point of transection, presumably· due to activation of regenerative 
processes. There have been several reports of elevated levels of 
polyamines and their associated enzymes in neoplastic tissue including 
tumors of the CNS (Kremzer et al., 1970; Snyder, S.H. and Russell, D.H., 
1969b; Ruseell, D.H., 1973). Levels of urinary polyamines may be 
elevated in patients harboring neoplasms (Russell, D.H., et al, 1971; 
Russell, D.H., 1973). Overall however, despite the high concentrations, 
there is little evidence concerning the function of polyamines in the 
CNS. 
I
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MATERIALS AND METHODS 
EXPERIMENTAL ANIMALS 
Only male Swiss Albino mice weighing between twenty and thirty 
grams were used in the present studies and were obtained from the same 
commercial source (Abrams Scientific Animal Farm, Madison, Wisconsin). 
They were housed four per cage in standard polyethylene cages 
(30 x 18 x 12 em.) with commercial pine sawdust as bedding. Unless 
otherwise indicated, food (Purina Rat Chow) and tap water were 
provided ad libitum. 
PROGRAMMED LIGHT-DARK CYCLE 
All animals were housed in quarters with an automatically-timed 
daily cycle of twelve hours of light and twelve hours of darkness. Light 
was provided using commercial Vita-Lite fixtures, emitting a spectrum 
of wavelengths similar to that of natural sunlight (Wurtman and Weisel, 
1969; McGuire et al., 1973). The ambient temperature in the quarters 
did not vary more than two to three degrees throughout the cycle. 
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Extraneous noise was kept to a minimum and the quarters were entered 
as seldom as possible during periods of entrainment and experimentation. 
All animals were adapted to the above conditions for at least . 
three weeks prior to experimentation. This has been shown to be more 
than adequate for the entrainment of most known endogenous rhythms in 
rodents (Bruce, 1960; DeCoursey, 1960). 
To facilitate various activities in the animal quarters during the 
dark phase of the cycle a small lamp emitting a dim red light was used 
since this spectrum has the least effect on circadian rhythms 
(McGuire et al., 1973). 
\ 
REAGENTS 
1. Only distilled-deionized water was used for preparation 
of solutions. 
2. Spermidine phosphate was obtained from Sigma Chemical 
Co. (St. Louis, Mo.). Solutions for animal injection 
and for bioassay experiments were prepared in 0.9% . 
sodium chloride. 
3. Cyproheptadine hydrochloride was kindly supplied by the 
Merck, Sharp & Dohme Company (West Point, Pa.). Because 
of its low· solubility in water, fine emulsions were 
made in 5% methylcellulose. Injections were made 
intraperitoneally with an 18 gauge needle at 0.1 ml./kg. 
4. Tripelenamine hydrochloride was kindly supplied by 
CIBA (Summit, N.J.).· Solutions were prepared in 0.9% 
sodium chloride. All doses were injected in a volume 
of 0.1 ml./kg. 
5. Pentobarbital sodium was prepared in 0.9% saline. A 
fresh solution was prepared prior to each individual 
experiment. 
6. Acetycholine hydrochloride was purchased from the 
Sigma Chemical Co. (St. Louis, Mo.). Solutions for 
bioassay. were freshly prepared in Tyrode•s solution. 
7. Decaborane (B10H14 ) was obtained from Alfa Inorganics, 
Inc. (Beverly, Mass.). The powder was dissolved in 
corn oil for intraperitoneal injection. 
8. Bio-Rex-63 was purchased from the Bio-Rad Company 
(Richmond, California). 
9. 0-phthaldialdehyde (OPT) was obtained from Sigma 
Chemical Company (St. Louis, Mo.). 
10. Tyrode•s solution was prepared according to the 
following formula. 
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REAGENT CONCENTRATIONS IN GM./LITER 
1. NaCl 8.00 
2. KCl 0.20 
3. CaC1 2 0.20 
4. NaHC03 1.00 
5. MgC1 2-6H2o 0.10 
6. NaH2Po4-H20 0.05 
7. Glucose 1.00 
The solution was prepared fresh for each separate preparation. 
TOXICITY STUDIES 
Intravenous injections of spermidine were given by tail vein. 
Intraperitoneal injections of spermidine and other preparations were 
given in the usual fashion. All injections were given in a volume of 
0.1 ml./kg. After the injections, animals were replaced in their 
original cages for an observation period of thirty minutes in the case 
of the intravenous toxicity study or for 270 minutes in the case of the 
intraperitoneal study. Appropriate dose levels were used in order to 
calculate the LD50. Ide~ical studies were carried out at regular 
intervals (four hours) throughout the light-dark cycle to determine 
the diurnal variation in the LD50. Mortality was attributed to the 
time period when the dose was given. ealculation of the LD50 was 
~iven~ Calculation of the LD50 was made according to the method of 
Litchfield and Wilcoxen (1949). Post-mortem examination was performed 
irrunediately after death in several .representative animals and some 
simple observations recorded. 
PROTECTION FROM THE TOXICITY OF SPERMIDINE 
Animals were pretreated with either 0.9% saline, cyproheptadine 
or tripelenamine given intraperitoneally thirty minutes prior to the 
administration of toxic doses of spermidine. As in previous studies, 
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a 270 minute observation period was used in the determination of total 
mortality. In separate experiments, increasing doses of cyproheptadine 
and tripelenamine \'/ere employed and a dose response curve constructed. 
MOTOR ACTIVITY RHYTHM 
Four animals had been entrained in the programmed light~dark 
cycle for three weeks as described above. Each was then adapted for 
three days to a cage equipped with a photo-cell. One count was 
recorded each time the animal interrupted the photobeam. Food and 
water were given ~lib. The pellets of rat chow and water container 
were located at the greatest distance from the photobeam as possible 
so as to minimize the recording of simple feeding activity. On the 
/ I 
II 
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fourth day the counts were recorded at regular intervals throughout 
the light-dark cycle. The average number of counts per hour for 
all four animals was then plotted versus time of day. Correlations 
were made with the diurnal variation of several different parameters 
of interest in this study such as the LD50. 
IN VITRO ACTIVITY 
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Male guinea pigs starved for the preceding 24 hours were killed 
at 1000 hours by a blow on the head. The abdomen was opened and the 
distal half of the small intestine to its junction with the cecum was 
isolated. The mesentery was carefully stripped away with fine 
ophthalmic scissors. The lumen was carefully cleared of fecal material 
by gently passing Tyrode's solution at 30° C through it using a 
standard blunt-tipped pipette. During preparation the strip of 
intestine was maintained in oxygenated Tyrode's solution. The distal 
3 em. segment was discarded. A 2-3 em. segment was then anchored at one 
end to a 10 milliliter bath while the other end was connected to a 
strain gauge. No counter balancing weight was used. Bath temperature 
was maintained at 30°C with a continuous stream of fine bubbles of 
oxygen. All solutions for injections were maintained in vials cooled 
with ice. 
A three minute agonist injection cycle was maintained. The bath 
was washed thirty seconds after injection of the agonist. All solutions 
/ 
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injected had been prepared in Tyrode's solution and thus their pH 
was identical to that of the perfusion bath. After successive 
responses to the agonist did not vary by more than two to three milli-
meters in amplitude, the effect of pretreatment with spermidine prior 
to the agonist was evaluated. The result was expressed as percent 
reduction in the amplitude of the average control response to the 
agonist. Injections of agonist alone were subsequently continued until 
the response returned to pretreatment levels. The effect of an 
isolated dose of spermidine on the spontaneous activity of the prepara-
tion was also determined. 
IN VIVO ACTIVITY 
Healthy mongrel dogs were anesthetized with intravenous pentothal 
sodium. Tracheostomy was performed on all animals. A continuous 
infusion of 5% dextrose in physiologic saline was maintained. Respira-
tions were recorded via a string attached to the chest wall and to a 
strain gauge. Electrocardiogram was monitored with standard limb leads. 
Blood pressure was monitored via an indwelling catheter in the femoral 
artery connected to a pressure transducer. All injections were made 
through an indwelling femoral venous catheter. Responses were recorded 
on a standard GrassR polygraph. 
SLEEPING TIME IN MICE 
Sleep was induced with intraperitoneal doses of sodium 
pentobarbital. Onset of sleep was defined as the moment of complete 
loss of righting reflex. Cessation of sleep was marked when the 
animal was able to walk 6 inches in any direction (without prodding). 
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The variation in response to a single dose of pentobarbital was deter-
minted at regular intervals (four hours) throughout the light-dark cycle. 
Rectal temperature was monitored during several experiments using a 
soft-tipped thermister probe connected to a continuous temperature 
monitor {Yellow Springs Instrument Co.). 
To determine the effect of injections of spermidine on pento-
barbital-induced sleep, groups of animals were pretreated with various 
doses of either spermidine or 0.9% saline. (In addition, a group of 
animals was given no pretreatment in order to determine the effect of 
the act of intraperitoneal injection alone on subsequent sleeping time.) 
Injections of pentobarbital sodium were given at several intervals 
after pretreatment. The optimum pretreatment interval was determined 
and used in all subsequent experiments. Although pretreatment with 
physiologic saline did not differ significantly from no pretreatment at 
all, this procedure was continued as the control in subsequent studies. 
Identical experiments were carried out at four hour intervals 
during the light-dark cycle to determine the diurnal fluctuation in the 
alteration in pentobarbital-induced sleeping time produced by spermidine. 
I 
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Central levels of histamine were depleted by the use of intraperi-
. 
toneal injections of decaborane as described by Medina et al. (1969). 
(This effect was confirmed by fluorimetric assay as described below.). 
Sleep was induced with pentobarbital sodium twenty-four hours after the 
injection of decaborane and in a group of controls not pretreated with 
decaborane. Some animals were pretreated with both decaborane and 
spermidine, 24 hours and 30 minutes re?pectively, prior to the injection 
of pentobarbital. Control animals received injections of corn oil 
(for decaborane) or 0.9% saline. All animals (including controls) were 
fasted after injection of the decaborane. Sleeping time was then 
determined as described above. 
Central histamine and spermidine levels were determined at 15 
minute intervals after the induction of sleep with pentobarbital. Two 
control animals were sacrificed at time zero. Either pentobarbital or 
0.9% saline was then injected into separate groups of animals. Two 
animals were sacrificed from the treated group at 15, 30, 45 & 60 
minutes after injection. At 60 minutes two control animals were again 
sacrificed along with the two treated animals. 
FLUORIMETRIC ASSAY OF SPERMIDINE AND HISTAMINE 
Tissue levels of histamine and spermidine were determined accord-
ing to the method of Michaelson and Coffman (1969) with minor modifi-
cations described below. The reliability and sensitivity of the method 
were evaluated. Aliquots of standard solutions of both amines were 
carri"ed through the entire procedure both alone and in combination 
with aliquots of tissue. 
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Animals were taken from the quarters and immediately killed by 
decapitation without anesthesia. The brain was carefully removed to the 
cervi come dull ary junction. The pons and me dull a were separated as a 
single specimen. The remainder of the brain (mesencephalon, thalamus-
hypothal. and hemispheres) was taken separately. Specimens were then 
placed in an aluminum-foil envelope, which was immersed in liquid 
nitrogen. This was easily accomplished within one to two minutes after 
decapitation. If needed, the entire liver was then removed and treated 
in a similar fashion. All samples were kept frozen until assayed. All 
tissues were assayed within or\e week of r·emova 1. 
PREPARATION OF TISSUES FOR ASSAY 
1. Tissues for assay were homogenized in 0.4N Perchloric 
acid containing 1 mg./ml. of EDTA. The volume of 
perchloric acid was equal to four times the weight of 
the tissue specimen in grams. 
2. The homogenizing vessel was kept in a container of 
ice during the homogenization. 
3. Homogenates were maintained in an ice bucket for ten 
minutes before centrifugation. 
/ 
4. The homogenates were then centrifuged (in their homo-
genizing vessel) at approximately 2200 rpm for ten 
minutes. For this short interval of spinning the tubes 
were cool at the termination of centrifugation. 
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5. A four ml. aliquot of the supernatant was then transferred 
to a shaker tube containing 0.5 ml. of 5N NaOH, 1.5 gm. of 
solid NaCl, 12 ml. of n-butanol. 
6. Tubes were then shaken four times in a vortex mixer for 
thirty seconds, resulting in excellent mixing. 
7. Shaker tubes were then centrifuged at 1000 rpm for ten 
minutes. 
8. The aqueous phase was then aspirated. Some solid NaCl 
was usually left in the bottom of the tube after this 
procedure. 
9. The remaining butanol phase was then shaken as above with 
5 ml. of a salt-saturated solution of 0. lN NaOH. 
10. Step #7 was repeated. 
11. A 10 ml. aliquot of the butanol phase was then transferred 
to another shaker tube containing 20 mg. of n-heptane 
and 1.5 mg. of 0. lN HCl. 
12. The tubes were shaken on the vortex mixer as above. 
13. Step #7 was repeated. 
14. One ml. of the aqueous phase was diluted in 9 ml. of 
0.2M phosphate buffer and adjusted to pH 6.0-6.2 with 
lN NaOH. (3-4 drops from a pasteur pipette were usually 
·required) 
15. The entire solution was then applied to the column. 
PREPARATION OF THE RESIN 
.1. An adequate volume of resin was hydrated in 4 volumes 
of distilled-deionized water. 
2. The mixture was then heated to 80 degrees (Fah~nheit) 
in a water bath for thirty minutes with constant stirring. 
3. The resin was then allowed to settle and the water plus 
any slowly settling particles of resin were decanted. 
4. The resin was then washed with 2 volumes of pure ethanol 
for ten minutes while stirring constantly. 
5. The ethanol was then removed through a Buchner funnel with 
tap suction. 
6. The resin was rehydrated in 4 volumes of distilled-deionized 
water while stirring constantly for 5 minutes. 
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7. The water was decanted along with any slowly settling particles. 
8. Resin was then slurried in a convenient volume of 2N HCl. 
One-half the volume of the resin bed was more than adequate. 
9. The column was formed by transferring the slurry via 
pipette to the bed. A 4 em. bed of resin was appro-
priate for use on a column of 5 millimeter diameter. 
ELUTION OF THE RESIN 
1. 10 ml. of 2 N HCl were passed through the column. This 
was sufficient to make a strongly acidic eluent. 
2. A sufficient quantity of deionized water vJas ·then passed 
through the column until the eluent was no longer acidic. 
Thirty ml. of water was usually more than enough. The 
pH of the eluent was followed with long then short range 
pH paper. 
3. A sufficient quantity of 1.5M NaOH was then passed through 
the column to make the eluent alkaline. One-half ml. of 
the 1.5 M NaOH diluted in 10 ml. of deionized water was 
adequate. 
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4. Deionized water was again used to remove all traces of alkali. 
Twenty ml. were usually required. 
5. 1 ml. 2N HCl diluted in 10 ml. deionized water was applied 
to make the resin eluent acidic once more. 
6. Deionized water, usually 20 ml., was used to elute all 
traces of the acid. 
7. 20-30 ml. of 0.2M buffer were then passed through the 
column. Amines or samples were added at this time by 
diluting them in the final 10 ml. aliquot of buffer 
being added. 
ELUTION OF AMINES 
1. The resin was first eluted with 50 ml. of D2N HN03. The 
eluate was discarded. 
2. 50 ml. O.lN HN03 was used to elute the histamine. This 
is collected, 1 ml. per tube, in test tubes suitable for 
development and reading. 
3. 40 ml. of 0.2N HN03 then eluted the spermidine and this 
was collected in 4 a1iljuots of 10 mi. each. 
DEVELOPfvlENT 
1. 1 ml. of each standard solution were developed along with 
a 1 ml. reagent blank consisting of the eluting agent 
used for whichever amine was being developed. 
2. Tissue blanks were prepared by adding the phosphoric acid 
prior to mixture with OPT. The final l ml. aliquot 
from both the histamine and spermidine eluates were used 
for this purpose. 
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3. Formation of the histamine - OPT fluorophore. 
a. 0.1 ml. of 4N NaOH 0 mix well. 
b. 0.05 ml. of 0.5% OPT- mix well and after 
2 minutes add 
c. 0.2 ml. of 3.5 ~ H3Po4 
4. Formation of the spermidine fluorophore. 
a. 0.3 ml. lN NaOH 
b. 0.05 ml. 0.2% OPT- mix well and after 6.5 minutes add 
c. 0.15 ml. 2.5~ H3P04 
FLUORIMETRIC READING 
1. Slit widths in order of sequence from light source to 
reading chamber in the Aminco-Bowman Spectra-fluorimeter 
\'ere 4-3-2-2. 
2. The 11 HV 11 scale was set at 0.8 
3. A quinine sulfate standard at 2.5 microgm./ml. was read 
at an excitation wavelength of 350mu and an emission 
wavelength of 450 mu at the above settings using a 30% 
scale. The fluorescence of this solution remained stable 
over long periods and was utilized to standardize the 
spectrofluorimeter for each experiment. 
/ 
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4. Tubes containing histamine with the appropriate standards 
were read at wavelengths of 350mu and 450mu. Spermidine 
were read at 350mu and 400mu. 
SENSITIVITY OF THE METHOD 
To assure more complete separation and recovery of histamine 
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and spermidine the columns were eluted with the appropriate solution 
until no trace of the amine in question could be detected in the 
eluate. This required volumes of eluent greater than those recommended 
in the original procedure of Michaelson and Coffman (1969). The 
recoveries after passing standard amounts of histamine or spermidine 
through the entire procedure, alone and in combination with tissue, 
are presented in Tables A and B. 
STATISTICS 
,.,,, 
The, paired 11 t 11 -test was employed in calculating levels of 
si gni fi cance. 
QUALITY OF RECOVERY OF HISTAMINE FROM THE METHOD OF MICHAELSON 
& COFH1AN ( 1969) 
TISSUE* AMT. ADDED AMT. RECOV'D. % RECOVERY ( rig ) ( ng ) 
none 50 49.5,52.5 102 
Whole brain none 340 
Whole brain 50 387 94 
none 100 98.7,96.1 97.4 
Liver none 226 
Liver 100 319 93 
none 200 201.5,196 99.4 
Whole brain none 352 
. 
Whole brain 200 535 91 
none 300 292,296 98 
Whole brain none 331 
Whole brain 300 620 92 
*All tissues collected at 1000 hr. from entrained animals 
TABLE A 
/ 
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QUALITY OF RECOVERY OF SPERMIDINE FROM THE METHOD OF 
MICHAELSON & COFFMAN {1969) 
TISSUE* AMT. ADDED AMT. RECOV'D. % RECOVERY ( ug ) ( ug ) 
none 25 22.8,25.0 96 
Whole brain none 117 
~Jhole brain 25 140 92 
none 50 50.5,47. l 97 
i ..; "'"' ._ 
"" __ ,... 
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Liver 50 92 92 
none 100 95.5,98.7 97 
none 150 148.5,146 98 
Whole brain none 106 
Whole brain 150_ 244 92 
*All tissues collected at 1000 hr. from entrained mice 
TABLE 8 
RESULTS 
GENERAL PHARMACOLOGY 
Acute intravenous toxicity 
Injection of sub-lethal doses of spermidine intravenously 
resulted in a consistent sequence of physiologic changes. Either 
immediately after the injection or occasionally before it was even 
completed, animals entered a brief period lasting from fifteen to 
thirty seconds characterized by i ncr·eased rnotor· activity i nterr·upted 
frequently by abrupt jumping high into the air. These signs 
invariably preceded all other signs of toxicity and in their absence 
no further signs appeared. Most fatalities occurred without 
progression to further stages and no deaths occurred that were not 
preceded by these signs. For purposes of future discussion, this 
period will be referred to as Stage I in the manifestations of 
spermidine toxicity. It was followed immediately by a period 
during which the animal remained rather stationary in a crouched 
position. Respirations became hyperpneic and labored with audible 
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gasping. Heart rate was regular and rapid. Vasodilatation was 
evident in the vessels of the ears and skin. Excessive salivation, 
lacrimation or defecation were not observed. Most affected animals 
were quite sensitive to the slightest tactile or auditory stimulus, 
jumping into the air when touched or with hand-clapping. The few 
animals that attempted to ambulate were clearly ataxic. This period, 
henceforth called Stage II, lasted up to fifteen minutes. All 
further fatalities occurred during this stage. Stage III was 
characterized by a gradual return of spontaneous motor activity 
and feeding behavior. Respiratory and heart rates declined to normal. 
Likewise, the piloerection and vasodilatation gradually disappeared. 
A more detailed evaluation of neurologic function was possible during 
this period. Animais were unable to balance on a glass rod at this 
time. Initial attempts at walking were characterized by dragging of 
the hind legs which were typically in a hyperextended posture with 
marked increase in motor tonus. Even after this resolved, their gait 
continued to be quite unsteady with weaving and frequent falls after 
which the animal had a great deal of difficulty righting itself. A 
mild hypersensitivity to tactile and auditory stimuli occasionally 
persisted into this stage. No fatalities occurred during Stage III. 
Diminishing signs of toxicity could be observed up to two hours after 
injection in animals receiving doses approaching the LD 50, There 
was no observable difference between mice who survived even 
potentially lethal doses of spermidine and those who received in-
jections of normal saline. 
Post-mortem examination of fatalities revealed only non-
specific gross pathologic changes. Examination of the heart revealed 
a deeply cyanotic myocardium implying significant hypoxia and 
hypercarbia. Excised lungs floated well in water~ indicating the 
absence of a major accumulation of pulmonary edema. The remainder 
of the major organ systems showed no obvious changes. 
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The LD 50 of spermidine phosphate varied significantly during 
the imposed light-dark cycle as shown in Table 1 and, in graphic form, 
in Figure 3. Peak LD 50 ( lowest toxicity ) occurred near the onset 
of the dark phase of the cycle. The lowest LD 50 ( peak toxicity ) 
was recorded just before the onset of the daylight phase. The 54.3% 
difference between these two points is highly significant (p <.0025). 
No alteration in the usual signs of toxicity nor their sequence was 
seen during the twenty-four hour cycle despite the change in the LD 50. 
The slope of the equation describing the LD 50 function also varied 
significantly. The steepest slope was recorded at the time of peak 
toxicity while the opposite was true of the time of least toxicity. 
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THE DIURNAL VARIATION OF THE LD 50 OF INTRAVENOUS SPERMIDINE 
*p<.0025 
n = 5 
TABLE 1 
• 
/ 
Legend for figure 3 and subsequent similar figures: 
abscissa= time in hours. Black bar represents 
period of darkness and open bar 
represents period of daylight. 
vertical brackets = + 1 S.D. 
FIGURE 3. DIURNAL VARIATION OF THE INTRAVENOUS LDSO OF SPERMIDINE 
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Intraperitoneal Toxicity 
The signs of toxicity after intraperitoneal injection were 
similar but not identical to those seen after intravenous injection. 
As expected, the signs of toxicity evolved in a more gradual fashion 
and persisted for a longer period of time. Without exception, the 
features of Stage I of the intravenous toxicity were not seen after 
intraperitoneal injection. Depending on the dose, the initial 
. indications of toxicity were seen as soon as two to three minutes 
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after injection, or they m1ght be delayed as long as ten minutes. 
The first manifestations consisted of signs which corresponded in 
essence and sequence to tho~e described as Stage II of intravenous 
toxicity. Thus, respiratory distress, tachycardia and vasodilatation 
appeared over a five to fifteen minute period. Hypersensitivity to 
envir6nmental stimuli could be demonstrated soon thereafter. Animals 
who attempted to walk were clearly unsteady and had a greatly impaired 
ability to right themselves after their frequent falls. At lower 
dose levels, these signs might be quite transient but at doses 
approaching the LD 50 they often persisted as long as three to four 
hours. Subsequently all signs subsided excepting the ataxic gait 
which was not seen after approximately four and one half hours. Deaths 
did not seem related to any specific stage of the intraperitoneal 
toxicity although very fe\'1 animals died who survived the stage of 
respiratory distress. No fatalities occurred after four and one 
half hours. No observable differences could be found .between treated 
and control animals after that ~ime. 
As with the intravenous toxicity, a significant diurnal 
variation in the intraperitoneal LD 50 was found (the peak LD 50 
differed from the trough LD 50 by 52.1%). A rise in the LD 50 was 
recorded near the transition from light to dark as seen with intra-
venous doses. In addition, another more variable peak was recorded 
just before the onset of light. The intraperitoneal LD 50 remained 
four to five times the value found with the intravenous route. Again 
the slope of the LD 50 function was greatest during periods of peak 
toxicity. 
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THE DIURNAL VARIATION OF THE LD 50 OF INTRAPERITONEAL SPERr~IDINE 
TABLE 2 
fiGURE 4. DIURNAL VJUUATION OF THE INTRAPERITONEAL LD fiO OF SPERMIDINE 
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Protect-ion from spermidine toxicity 
As seen in table 3, tripelenamine tends to reduce the 
mort a 1 ity from i ntraperitonea 1 doses of spermidine. Hmvever, 
this reached statistical significance only at a dose of 15 mg/kg 
of tripelenamine and the 500 mg/kg dose.of spermidine. Higher 
doses of tripelenamine v1ere found to produce signs of toxicity of 
themselves (lethargy, ataxia and occasional fatalities). This 
protective effect has been previously reported from this laboratory 
(Friedman and Rodichok, 1970). 
Cyproheptadine \'Jas considerably more effective in protecting 
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from spermidine toxicity as seen in Table 4. At a dose of 0.5 mg/kg 
there was a highly significant incr·ease in the LD 50 (reduced toxicity) 
as compared to unprotected animals (p~ .02). Fatalities in the protect-
ed group showed the usual signs of spermidine toxicity. 
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MORTALITY AFTER INTRAPERITONEAL SPERMIDINE. 
PROTECTION WITH TRIPELENAMINE. 
- PRE-TREATMENT 
NONE TRIPELENM1INE 
DOSE OF SPD 5.0 mg/kg 10 mg/kg 15 mg/kg 
1000 mg/kg 11/11 11 /ll 11/11 11/11 
750 mg/kg 9/11 10/11 6/11 5/11 
-
500 mg/kg 6/11 6/11 5/11 2/11 
1n ;::,n t ......... n,-\ .. Jii:.O..L. * I l{)rJ ..i... * .. 
L-V <JV \Ill~/"'~ I -rvu~ 1 ;n.. ;:.. 
+ 1 S.D. 125 123 
-
* p = • 05 
n = 11 
TABLE 3 
/ 
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MORTALITY AFTER INTRAPERITONEAL SPERMIDINE. 
PROTECTION WITH CYPROHEPTADINE 
PRE-TREATMENT 
NONE CYPROHEPTADINE 
DOSE OF SPD 0.1 mg/kg 0.25 mg/kg 0.5 mg/kg 
1000 mg/kg 11/11 11/11 11/11 9/11 
750 mg/kg 9/11 9/11 6/11 2/11 
500 mg/kg 6/11 
• LD 50 (mg/kg . I I .. 468 ± * 865 + * 
+ 1 S.D. 125 107 
-
* p <. 02 
' 
n = 11 
TABLE 4 
MOTOR ACTIVITY RHYTHM IN MICE 
The true circadian nature of motor activity rhythms in rodents 
is vvell known (DeCoursey, 1960). As seen in Figure 5, this rhythm 
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was v1ell entrained by the environmental conditions used in this study. 
Peak activity occurred in anticipation of the onset of darkness and 
gradually receded as daylight approached. An inconsistent peak 
often occurs at the onset of light as in this study. The difference 
betv1een peak and trough values is significant { p <. .001 ). The 
secondary peak at the onset of daylight did not reach statistical 
significance in this study. 
Figure 6 depects in graphic form the correlation between the 
motor activity rhythm and the rhythm for intravenous spermidine 
toxicity. Both peak LD 50 and peak motor activity just anticipate the 
onset of darkness. Similarly, a less significant peak can be seen 
in both rhythms at the onset of daylight. 
The correspondence between the rhythm of intraperitoneal 
spermidine toxicity and motor activity is less remarkable as seen in 
Figure 7. Nevertheless, significant peaks occur in the toxicity rhythm 
at approximately the same times as in the activity rhythm. 
Fig::..zre5. Diurnal variation of the motor activii·y of rnke 
-
.;.., 
·-> 
·-<-
u 
1200' 
1000. 
400· 
0 200 
II... 
0 
~ 
0 
:E 
FIGURE 6. DIURNAL VARIATION OF THE INTRAVENOUS TOXICITY OF SPERMIDINE 
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IN VITRO ACTIVITY 
Spermidine had no effect.on the acetylcholine-induced 
contraction of guinea-pig ileum 0hen i~jected after the agonist. 
A consistent reduction in the a~plitude of contractile response was 
seen however when spermidine was injected ten seconds prior to the 
acetylcholine. At a final concentration of 0.8ui•1 spermidine resulted 
in appro~imately a 20% reduction in amplitude. At concentrations of 
l.6uM.and 3.2uM, a 50% reduction was seen. Higher concentrations 
produced no greater effect. Control injections of Tyrode's solution 
had no effect. When injected more than ten seconds prior to the 
agonist, spermidine had no effect. Spermidine did not affect con-
tractions. induced with barium. Figure 8 shows representative examples 
of the effect of spermidine injected ten seconds before acetylcholine. 
At increased sensitivity (.02mv/cm) the effect of spermidine 
on the spontaneous activity of the guinea-pig ileum can be seen 
(Figure 9). At a final concentration of 1.6uM there is a significant 
reduction of the amplitude of the spontaneous contractions although 
the frequency is unchanged. A small depression of the baseline 
muscle tone occurs. Control injections of Tyrode's solution had no 
effect. 
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Fi ,ure 8. The effect of s ermidine on the acet• lcholine-i::9;.ced contraction of guinea pig ilc"Jm 
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Figure 9. The effect of spermidine on the spontaneous <:•Gtivity of guinea pig iisum 
10 sec. 
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IN VIVO EFFECTS OF SPERMIDINE IN DOGS 
Injection of 0.75 - 1.00 mg/kg dose of spermidine intra-
venously was sufficient to produce a marked cardio-pulmonary response. 
A prompt reduction in the mean blood pressure and a rise in the 
pulse pressure were associated with hyperpnea and tachycardia. 
These parameters showed a gradual recovery over the following one 
to two minutes (Figure 10). Injections of histamine at a dose of 
5 ug/kg produced a very similar response (Figure 10). Following 
the first effective dose of spermidine, subsequent injections were 
of little or no significant effect. 
Intravenous injection of 200 mg/kg spermidine caused 
instantaneous loss of detectable blood pressure and irreversible 
apnea. Cardiac electrical activity was detectable for a short time 
thereafter, showing marked ST-T segment depression and T-wave 
inversion. 
FIGURE 10. RESPONSE TO INTRAVENOUS SPERr"l!D!NE (a)8.: H!STAMH~E{b)IN THE DOG 
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BARBITURATE-INDUCED SLEEPI~G TIME IN MICE 
1. The effect of pre-treatment with spermidine on the duration of 
barbiturate-induced sleeping time. 
Pre-treatment with doses of spermidine significantly 
prolonged sleep after sodium pentobarbital. This effect was 
clearly maximal when the spermidine was given thirty minutes 
prior to sleep induction. A suggestion of a similar result was 
seen with doses given sixty minutes before while no change 
occurred with pre-treatment at 120 minutes. A dose of 300 mg/kg 
was approximately twice as effective as 150 mg/kg. It is of 
interest to note the mild alteration in duration produced by 
sham pre-treatment with physiologic saline. Though not 
statistically significant, all subsequent studies utilize this 
form of control for reasons to be discussed later~ Table 5 
summarizes these data. 
2. Diurnal variability of the duration of barbiturate-induced 
sleeping time and the effect of pre-tteatment with spermidine 
thereon, 
The duration of barbiturate-induced sleep in mice varied 
significantly during the programmed twenty-four hour light-dark 
·cycle (Table 6 and Figure 11). Peak duration occurred in 
anticipation of the onset of daylight while a trough was seen 
just prior to the onset of the dark phase. The difference 
between these values is significant ( p < .001}. As seen 
in Figure 11, the duration of sleep was inversely related 
to motor activity. 
The prolongation of sleep produced by pre-treatment 
with sperm·idine was likevtise time-dependent (Table 6). The 
diurnal curve maintains the same phase relationships as with 
barbiturate alone (Figure 11), peak sleeping time occurring 
just priot' to the onset of daylight. Spermidine seemed to 
abolish the trough appearing just prior to the onset of 
darkness, the point at which the greatest relative increase 
over control vvas seen (Table 6). This is the time period of 
- .. ~ .. 
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66 l THE EFFECT OF PRETREATMENT WITH SPERMIDINE ON BARBITURATE-INDUCED SLEEP 
l...--
1 
DURATION OF SLEEP (Minutes + 
-
l S.D.) 
Minutes prior to none saline 
barbiturate i nj. 
30 41± 3 45+ 6 
-
60 41± 3 45± 6 
120 41± 3 45+ 6 
* p < .05 (versus saline control) 
**p < .001 (versus saline control) 
n = 5 
TABLE 5 
Pre-Treatment 
Spd-l50mg/kg Spd-300mg/kg 
57± 3* 71± 2** 
48+ 2 53:!; 3 
-
38:!: 3 41± 2 
-~--- -- - ~ ----- -·~ ...-....--...-...-- _..,._.-----
FIGURE 11. DIURNAL VARIATION OF SLEEP AFTER PENTOBARBITAL(o---e) INCREASED BY SPERMIDINE{.6.--A) 
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DIURNAL VARIABILITY IN THE DURATION OF SLEEP AFTER PENTOBARBITAL 
ALTERED BY PRETREATMENT WITH SPERM I DINE 
Time 
0200 
0600 
1000 
1300 
1900 
2200 
* p <,05 
** p <. 001 
*** p " . 001 
n= 5 
Duration of sleep (minutes ± l S.D.) 
Pre-Treatment 
saline Spd-300mg/kg 
54± 4.6 71± 2.6 
* 63± 7.5 ** 76± 7.2*** 
44± 5.2* 60± 2.2*** 
43± 2.9 62± 6.7 
29± 3.0** 67+ 4.9 
39± 5.4 71± 1.0 
TABLE 6 
% increase 
32 ( p < • 01) 
38 ( p < . 05) 
36 ( p < • 02) 
45 ( p < • 05) 
135( p <. 001) 
86 ( p <.001) 
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3. Interaction between central biogenic a~ine depletion, sleeping 
time and spermidine. 
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Decaborane has been shown to deplete the levels of 
several biogenic amines in the CNS, maximally at a point twenty-
four hours after injection (von Euler and Lishajko, 1965; 
Merritt and Sulkowski, 1967; Medina et al., 1969). No attempt 
was made to duplicate all of these studies. The effect of 
decaborane on central histamine levels was confirmed. In 
addition, a significant reduction of central spermidine was 
demonstrated as seen in Table 7. 
Pre-treatment with decaborane markedly prolonged the 
duration of sleep after pentobarbital. Whereas a dose of 
pentobarbita1 of 30 mg/kg. is insufficient to produce sleep in 
control animals. A dose of 60 mg/kg was followed by only 
42 ~ 3 minutes of sleep in the control group. At this dose of 
pentobarbital, of twelve animals pre-treated with decaborane 
six died after periods of deep sleep and six slept for periods 
exceeding 120 minutes but survived. Spermidine alone did not 
produce sleep in pre-treated animals nor did the usual signs of 
toxicity seem altered. Pretreatment with both decaborane and 
spermidine significantly prolonged the duration of sleep as 
compared to pre-treatment with spermidine alone but this combin-
ation was less effective than decaborane alone. These data are 
summarized in Table 8. 
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REDUCTION OF WHOLE BRAIN HISTAMINE AND SPERMIDINE LEVELS 
HJENTY-FOUR HOURS AFTER DECABORANE 
Control 
Decaborane 
* p < • 001 
**p < .05 
n = 3 
Whole brain histamine 
( n g I gm : 1 S • D • ) 
318 ± 9* 
168 ± 12* 
TABLE 7 
Whole brain spermidine 
(ug/gm ± 1 S.D.) 
109 ± 7** 
82 ± 8** 
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THE EFFECT OF PRETREATMENT WITH DECABORANE &/or SPER~H DINE 
ON THE DURATION OF SLEEP AFTER PENTOBARBITAL 
Pretreatment Pentoba rbita 1 sleep duration 
Db Spd 30mg/kg 60mg/kg (min.± l S.D.) 
- -
+ - 0 
- - -
+ 42 + 3 
-
-
+ + - 15 + 2* 
- + - + 60 ± 2 
+ - + - 70 ± 5* 
+ 
- -
+ 6 deaths & 
6 slept 120 min. 
+ + 
- -
0 
+ + + - 41 ± 4 
+ + - + 12/12 deaths 
Db = Decaborane, 15mg/kg intraperitoneally 24 hours prior to 
sleep-induction 
Spd =Spermidine, 300 mg/kg i.p. 30 min. prior to sleep-induction 
* p < .001 (versus control injection of corresponding dose of 
pentobarbita 1 alone) 
TABLE 8 
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4. The time course of histamine and spermidine levels during sleep 
induced by pentobarbital. 
Table 9 demonstrates the reduction in central histamine 
levels during barbiturate-induced sleep. A maximum reduction 
of 22% was seen forty-five minutes after the onset of sleep. 
Significant reduction of midbrain and caudate histamine levels 
by pentobarbital has been reported previously in rats (Friedman, 
A.H. and Walker,C.A.,1969). Little change occurred in the levels 
of spermidine during sleep , the maximum reduction being 11% at 
forty-five minutes (Table 9). 
DIURNAL VARIATION OF HISTAt~INE AND SPERI>1IDINE LEVELS 
IN WHOLE BRAIN,MYELENCEPHALON AND LIVER. 
HISTAMINE 
Levels of histamine were highest in ~~~/hole brain 11 (mesencephalon, 
hypothalamus-thalamus and hemispheres). Significant levels were also 
detected in the medulla-pons and liver. During the programmed light-
dark cycle peak levels occurred in all three tissues just prior to 
the onset of the dark phase. Lowest levels \vere reached within four 
hours after the onset of darkness (Table 10 and Figure 12). 
r-
r-
TIME COURSE OF v!HOLE BRAIN HISTAMINE AND SPERMIDINE 
DURING BARBITURATE-INDUCED SLEEP 
minutes after injection 
control 15 30 45 60 
\!lhole brain histamine * * 
(ng I gm) 222 202 197 173 202 
Whole brain spermidine 
(ug I gm) 45.5 48.5 42.5 40.0 43.0 
n = 2 
*p = .01 - four control animals (226 :!: 6. 1 nglgm) compared 
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control 
225 
48.0 
to 
. ' 
~ .... I "" ,.. ,- ~ . \ . four· an1n1als col1ecteu ctt 3u & 4o mHiu-ces ~ 1~:::> ! JLt ng;gm) 
TABLE 9 
/ 
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SPERMIDINE 
Levels of spermidine were higher in the medulla-pons than in 
the whole brain. Relatively low concentrations were detected in the 
liver. Levels in all three tissues showed a diurnal variability 
similar to that of histamine. Peaks occurred just before the onset 
of darkness while lowest levels were found at the onset of tf1e day-
light phase. In the case of the medulla-pons and whole brain , 
higher levels were still present four hours after the onset of 
darkness (Table 10 and Figure 13). 
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DIURNAL VARIABILITY IN THE LEVELS OF HISTAMINE AND SPERMIDINE IN w"HOLE BRAIN, MYELENCEPHALON & LIVER 1 
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FIGURE 12.DIURNAL VARIABILITY OF HISTAMINE LEVELS 
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FIGURE 13.DIURNAL VARIABILITY OF SPERMIDINE LEVELS 
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DISCUSS ION 
Few studies of the in' vivo acute toxicity of S!Jermidine have 
been reported. Intravenous injections of both spermine and spermidine 
have been reported to cause transient hypotension and respiratory 
distress (Tabor, C.W., and Rosenthal, S.M.~ 1956). In a more.recent 
study, Shaw (1972) reported sedation, respirator_y distress and ataxia 
after parenteral injections of both spermine and spermidine. Lethal 
doses were attended by clonic convulsions as well. In the present 
study intravenous injections of spermidine in mice were foi1ov1ed 
immediately by a brief period of hyperactivity (Stage I). Stage II 
of the intravenous toxicity and the first signs of intraperitoneal 
77 
toxicity were marked by severe respiratory distress, tachycardia and 
cutaneous vasodilatation. Deaths occurred in ei.ther Stage I (intra-
venous) or Stage II and were often preceded by agonal myoclonic seizure 
activity. Survivors of these stages showed a variable period 
(Stage III) of ataxia, motor retardation and hypersensitivity to noise 
and tactile stimuli. In sub-lethal ·doses little effect was seen on 
rectal.temperature. Although a direct action of spermidine cannot be 
excluded, these effects are quite similar to those seen after 
injections of histamine (Douglas, W.W., 1968; Kahlson~ G. and 
Rosengren, E., 1965). This is supported by the simi lRrity in response 
to intravenous injection of histamine and spermidine in dogs 
I 
t 
l 
I 
I 
t 
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demonstrated here. Although this response was easily distinguished from 
that of serotonin in the dog, the effects of this amine vary with 
different species and are often quite similar to those of histamine. 
Cyproheptadine has been shown to have both potent anti-histaminic and 
anti~serotonergic properties (Stone, C.A. et al, 1961; Van Reizen, H., 
1972). The fact that this compound offered greater protection from 
the toxicity of spermidine than did tripelenamine, an anti-histamine 
which has no significant anti-serotonergic activity, suggests that 
both histamine and serotonin may be released by spermidine. Neither 
spermidine nor spermine pass the blood brain barrier (Snyder, S.H. et al., 
1973) and thus a primary central site of action can be dismissed. 
Platelets and masts cells, storage sites for both histamine and 
serotonin, are possible sites of action·for spermidine. Other 
polyamines such as the polymer 11 48/80 11 are potent releasers of 
biogenic amines from these sources (Rothschild, A.M., 1970). In the 
present study, dogs showed a marked tachyphylaxis to spermidine in-
jections. This could very well be due to depletion of histamine and 
serotonin stores after the first effective doses and would therefore 
lend support to the notion that spermidine acts by releasing these 
amines. Tachyphylaxis is characteristic of the pharmacology of both 
histamine and serotonin. 
Effective and lethal doses of spermidine were considerably 
higher with intraperitoneal as compared to intravenous administration. 
.· 
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This might be explained on the basis of incomplete and/or slow 
absorption through the peritoneum, resulting in lower and less 
effective blood levels. An additional factor however might be that 
spermidine is inactivated during absorption by this route. Diamine 
oxidase catalyses the oxidation of both spermidine and histamine and is 
present in significant quantities along the gastrointestinal tract 
(Kim, K.S., et al., 1969). This enzyme may have oxidized a 
significant proportion of intraperitoneal doses of spermidine. Diurnal 
variation in the activity of this enzyme has not been studied and,if 
significant, could further complicate studies using this route. 
Diurnal variability in the LD50 of spermidine has not been 
studied previously and must be considered in future experimentation. 
The intravenous LD50 in mice repm'ted by Shaw (1972) (78 mg/kg) is 
somewhat lower than values reported here but a lighting regimen 
was not utilized. Factors underlying such a variation are likely to 
be multiple. The significant fluctuation in spermidine levels shown 
here may in part reflect changes in the activity of catabolic enzymes. 
The abrupt change in the slope of the intravenous LDSO curve seen at 
the point of highest toxicity is significant. Steepening of the 
curve must indicate either an alteration of the turnover of spermidine 
or heightened receptor sensitivity (Nelson, W., and Halberg, F., 1973). 
The correlation of lowest toxicity with peak endogenous ·levels of 
spermidine may point to a decrease in catabolism. The decrease in 
l 
I 
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spermidine toxicity occurs at a time when endogenous histamine levels are 
highest and serotonin levels are low. Endogenous levels of these as 
well as other biogenic amines often correlate with increased release 
I 
and catabolism (Kahlson, C. and Rosengren, E., 1968; Hery, F. et al., 
1972; Mandell, A.J. et al., 1974). The functional significance of such 
a correlation is therefore unclear without further study. Since no 
change in the manifestations of toxicity was seen within the twenty-four 
hour cycle, a change in mode of action is unlikely. 
The ~vitro activity of spermidine was not extensively studied 
here. Polyamines have been previously shown to antagonize the con-
traction of guinea pig ileum induced by a variety of agents including 
acetylcholine, histamine, 5-HT and nicotine (Der~eis, L., 1967; Onodera, K., 
et al, 1968). DeMeis and DePaula (1967) and Nagai et al.(l969) have 
both reported a specific inhibition of magnesium-activated ATP-ase of 
myofibrils, myosin B and native actomyosin by polyamines. A similar 
action on vascular smooth muscle might explain the hypotension and 
cutaneous vasodilatation seen after spermidine injection but would not 
account for many of the other manifestations. 
The basis for the well-established hypnotic effect of 
. barbiturates is not known. The duration of sleep after appropriate 
doses is dependent on many factors. Reduction of ambient room tempera-
ture below 30°C prolongs the duration of barbiturate-induced sleep 
(Raventos, J., 1938). Several drugs known to potentiate the hypnotic 
I 
t 
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effect of barbiturates owe their action to their ability to induce 
hypcthermia (Lessin, A.W., and Parkes, M.W., 1957). The 
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environmental temperature was therefore kept constant during this study. 
Although lethal doses of spermidine were associated with agonal hypother-
mia, no significant change in rectal temperature was seen with 
doses used to evaluate the effect of spermidine on pentobarbital-induced 
sleeping time. At the dosage utilized in the present study (60 mg/kg) 
pentobarbital-induced sleep was attended by a decline of rectal tempera-
ture of approximately soc. This was unaffected by pre-treatment with 
spermidine. Nevertheless, pretreatment with spermidine prolonged 
the duration of sleep after pentobarbital. Since spermidine does not 
pass the blood-brain barrier, the basis for this effect must be peripheral. 
This would not exclude the possibility of the r2lease of a centrally 
active compound. Both serotonin and histamine have been shown to 
P,rolong drug-induced sleeping time and, as noted above, could have been 
released by spermidine (Fastier, F.N., et al., 1957). Polyamines might 
also conceivably inhibit the degradation of barbiturates by the liver, 
thus elevating CNS concentrations of the drug and prolonging sleeping 
time. As noted above,this would be consistent with the association of 
polyamines with active synthesis, particularly in the liver. 
A diurnal rhythm in the duration of barbiturate-induced sleep 
as shown in the present study, has been reported previously (Davis, W.M., 
1962; Lindsay H.A. and Kullman, V.S., 1966; Scheving, L.E. et al, 1968b). 
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In most nocturnal species peak duration occurs during darkness and 
corresponds to the period of peak motor activity and highest body 
temperatures. This may in part be related to the diurnal rhythm of 
hepatic drug metabolism (Radzialowski, F.M. and Bousquet, W.F., 1968; 
Jori, A., et al., 1971). However, recent studies have implicated a 
change in receptor sensitivity to barbiturates as well (Nelson, W. 
and Halberg, F., 1973). 
Decaborane reduces central levels of norephinephrine and serotonin 
as well as histamine. (Von Euler, U.S. and Lishajko, F., 1965; Merritt, 
J.H. and Sulkowski, T.S., 1967; Schayer, R.W. and Reilly, M.A., 1971). 
Its effect on PST seen in this study certainly suggests that the 
effect of barbiturates on sleep involves one or more of these biogenic 
amines. In contrast to the rat (Friedman, A.H. and Walker, C.A., 1969) 
pentobarbital caused a small but significant reduction in central histamine 
levels, perhaps the basis of its synergism with decaborane. Even if 
spermidine releases peripheral stores of histamine or serotonin 
neither of these biogenic amines enter the CNS in effective concentrations. 
However, spermidJne alone also prolonged PST. This effect was significantly 
increased during the transition from light to dark. This is the period 
of least toxicity of spermidine, suggesting that the action on PST is 
mediated differently, perhaps by competition for enzymes in the liver 
metabolizing the pentobarbital. 
'--------------~- J 
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Daily fluctuation in the levels of many of the biogenic amines 
is well established {Scheving, L.A. et al, l968a; Friedman, A.H. 
and Walker, C.A., 1969; Piepho, R.W. and Friedman, A.H., 1971; Saita, Y., 
1971; Walker, C.A. et al., 1971). Peak levels of histamine in rat 
brain have been found early in the dark phase of the cycle (Friedman, A.H., 
and Walker, C.A., 1969; Garbarg, M. et al., 1974). In the present 
study of the mouse, peak levels of histamine in brain and liver just 
anticipated the dark phase. The association of elevation of histamine 
levels with the period of greatest motor activity is in keeping with 
recent interest in the activating effect of histamine on the CNS 
(Monnier, M. et al., 1970; Taylor, K.M. and Snyder, S.H., 1971). 
Depletion of histamine levels by decaborane correlated with increased 
sleeping time. Stress caused by cold or restraint is associated with 
increased turnover of histamine (Taylor, K.M. and Snyder, S.H., 1972). 
Intraventricular injections of histamine have a definite awakening 
effect (Monnier, M. et al., 1970). 
Significant diurnal variability in polyamine levels has not 
been reported previously. The phase of this rhythm was the same as that 
of histamine. Recent studies have renewed interest in a possible 
interaction between histamine and spermidine. As discussed above, 
both are associated with periods of raPid growth, particularly during 
embryogenesis. During these periods, a significant proportion of 
histamine is localized within the nucleus as is spermidine (Kuhar, M. 
et al., 1971; Young, A.B. et al., 1971; Snyder, S.H., and Kuhar, t1., 
1972). The parallel reduction of histamine and spermidine levels 
during barbiturate-induced sleep shown here supports this association. 
On the other hand, a significant fraction of histamine in adult neural 
tissue is associated with synaptic elements and has some features of a 
true neurotransmitter (Snyder, S.H. and Kuhar, M., 1972). Polyamines 
are not known to be associated with this fraction. 
84 
The studies reported here are clearly preliminary and incomplete. 
In studying the acute toxicity of spermidine a picture consistent with 
a release of histamine and serotonin was seen. The prolongation of 
barbiturate-induced sleeping time after pretreatment with spermidine may 
be mediated differently. The diurnal fluctuation in spermidine levels 
and toxicity has not been previously established and must be considered 
in future studies. Further investigation into the neuropharmacology 
of the polyamines seems warranted. 
I· 
SU~1MARY 
Some pharmacologic properties of the polyamine spermidine have 
been studied. Toxicity in mice after intravenous injection consisted 
of acute respiratory distress and myoclonic seizures followed by 
a period of lethargy, ataxia and irritability. Intraperitoneal doses 
produced a similar sequence of signs evolving over a longer period. 
Significant diurnal variability of the LD 50 was found with a peak 
for both the i.v. and i.p. routes occurring during the transition from 
light to dark in a programmed 24 hour cycle of twelve hours of light 
and twelve hours of darkness. This peak corresponded to the peak of 
the daily motor activity rhythm. Pretreatment with either cypro-
heptadine or tripelenamine significantly reduced the LD 50 of 
spermidine. Intravenous doses of spermidine in dogs caused acute 
hypotension, tachycardia and tachypnea and were associated with 
marked tachyphylaxis. Injections of histamine produced a very 
similar picture. Neither the diurnal fluctuation of the LD 50 of 
spermidine nor its alteration by tripelenamine and cyproheptadine have 
been reported previously. 
Pretreatment with spermidine reduced the amplitude of acetyl-
choline-induced contraction of guinea pig ileum. The amplitude of 
the intrinsic rhythmic activity was also transiently diminished after 
spermidine. 
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The di urn a 1 variability in barbiturate-induced sleeping time was 
confirmed) peak dur::ition occurring late in the dark phase of the 
cycle. Pretreatment Vtith spet'midine significantly prolonged sleeping 
time. This effect 1·1as variable in magnitude during the 24 hour cycle , 
peak prolongation occurring at the transition from l~ght to dark ~ 
the time period of peak LD 50 of spermidine and highest levels of 
endogenous spermidine and histamine. 
A diurnal rhythm of endogenous levels of spermdine and histamine 
was established in whole brain, myelencephalon and liver. Highest 
levels of both amines occurred just prior to the onset of darkness • 
... -------~~~~--------------~-~~--~~-·····--~ ---~----····----~---~~ 
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